1334953-75-1 Usage
Uses
Used in Pharmaceutical Research and Development:
N-((5-(4-chloroquinazolin-6-yl)furan-2-yl)Methyl)-2-(Methylsulfonyl)ethanaMine is used as a potential candidate in pharmaceutical research and development due to its unique chemical structure and the presence of bioactive functional groups. Its quinazoline and furan rings, along with the methylsulfonyl group, may contribute to its potential therapeutic properties, making it a promising target for medicinal chemistry investigations.
Used in Medicinal Chemistry Investigations:
In the field of medicinal chemistry, N-((5-(4-chloroquinazolin-6-yl)furan-2-yl)Methyl)-2-(Methylsulfonyl)ethanaMine is used for exploring its potential applications in the treatment of various medical conditions. Its structural features, including the quinazoline and furan rings, as well as the methylsulfonyl group, may provide insights into its interactions with biological targets and contribute to the development of new therapeutic agents.
Used in Drug Design and Optimization:
N-((5-(4-chloroquinazolin-6-yl)furan-2-yl)Methyl)-2-(Methylsulfonyl)ethanaMine can be used in drug design and optimization processes to identify and improve its pharmacological properties. By studying its interactions with biological targets and understanding its structure-activity relationships, researchers can modify and optimize its chemical structure to enhance its therapeutic potential and minimize potential side effects.
Used in Drug Discovery:
In the drug discovery process, N-((5-(4-chloroquinazolin-6-yl)furan-2-yl)Methyl)-2-(Methylsulfonyl)ethanaMine serves as a starting point for identifying new drug candidates. Its unique chemical structure and potential bioactivity make it a valuable compound for screening and evaluating its efficacy in treating specific medical conditions. Further research and development can lead to the discovery of novel therapeutic agents with improved safety and efficacy profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 1334953-75-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,4,9,5 and 3 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1334953-75:
(9*1)+(8*3)+(7*3)+(6*4)+(5*9)+(4*5)+(3*3)+(2*7)+(1*5)=171
171 % 10 = 1
So 1334953-75-1 is a valid CAS Registry Number.
1334953-75-1Relevant academic research and scientific papers
Process for the preparation of lapatinib and the salts thereof
-
, (2012/07/03)
The present invention refers to a new process for the synthesis of the pharmaceutical active ingredient Lapatinib and the salts thereof. In particular, the present synthesis is performed using intermediates in which the hydroxyl function is protected by the tetrahydropyranyl group hence entailing greater solubility of the intermediates in the common organic solvents.
METHODS FOR THE PREPARATION OF LAPATINIB AND THE SALTS THEREOF
-
, (2012/10/08)
Methods for the synthesis of the pharmaceutically active ingredient Lapatinib and the salts thereof are provided. In particular, such methods utilize intermediates in which the hydroxyl function is protected by a tetrahydropyranyl group providing greater solubility of the intermediates in common organic solvents.
PROCESS AND INTERMEDIATES FOR PREPARING LAPATINIB
-
Page/Page column 19, (2011/10/13)
Provided are a process for preparing lapatinib and its pharmaceutically acceptable salt by use of new intermediates, and a process for obtaining a pharmaceutical form of lapatinib ditosylate monohydrate.
